Abstract
Primary tumors of the parotid gland arise either in the superficial lobe, deep lobe, isthmus, accessory lobe, or Stensen’s duct, which will result in different behaviors concerning local spread and different clinical presentations. The various topographic and histologic possibilities, especially in the presence of extended tumors, will lead to a difficult differential diagnosis. Primary tumors must be differentiated from involvement of the parotid gland by direct invasion from tumors in neighboring areas and from metastatic disease to the parotid gland. Clinical suspicion is extremely important in order to properly address unusual individual cases and avoid the trap of approaching all parotid masses in the same manner that could eventually lead to either unnecessary or incomplete treatment. The suspicion is raised first by clinical examination and will be strengthened by further imaging studies, and eventually the final diagnosis will be confirmed by pathology. A great variety of histological types have been described in primary as well as secondary tumors to this area. Although statistical data suggests a great prevalence of certain malignant parotid tumors over others, the surgeon must not underestimate the possibility of rare tumors arising in this area that may require a different therapeutic approach. It is a challenge for the surgeon to manage certain complex tumors encountered in the parotid area. The aim of establishing the origin of the extended parotid gland tumor is to tailor the treatment according to the known behavior of tumors originating in the parotid tissue and to avoid the danger of under- or overtreatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ho K, Lin H, Ann DK, Chu PG, Yen Y. An overview of the rare parotid gland cancer. Head Neck Oncol. 2011;14(3):40. doi:10.1186/1758-3284-3-40.
Afify SE, Maynard JD. Tumours of the accessory lobe of the parotid gland. Postgrad Med J. 1992;68:461–2.
Lin DT, Coppit GL, Burkey BB, Netterville JL. Tumors of the accessory lobe of the parotid gland: a 10-year experience. Laryngoscope. 2004;114(9):1652–5.
Tamiolakis D, Chimona TS, Georgiou G, Proimos E, Nikolaidou S, Perogamvrakis G, Papadakis CE. Accessory parotid gland carcinoma ex pleomorphic adenoma. Case study diagnosed by fine needle aspiration. Stomatologija Balt Dent Maxillofac J. 2009;11:37–40.
Attie J, Sciubba J. Salivary gland neoplasms. Chicago: Year Book Medical Publishers; 1981.
Myers EN, Ferris RL. Salivary gland disorders. Berlin: Springer-Verlag; 2007.
Tominaga Y, Uchino A, Ishimaru J, Inokuchi A, Sato S, Kudo S. Squamous cell carcinoma arising from Stensen’s duct. Radiat Med. 2006;24(9):639–42.
Close L, Larson DL, Shah JP. Essentials of head and neck oncology. New York: Thieme; 1998.
Harnsberger H, Osborn A. Differential diagnosis of head and neck lesions based on their space of origin. I. The suprahyoid part of the neck. AJR. 1991;157:147–54.
Myers EN, Ferris RL. Master techniques in otolaryngology – head and neck surgery, vol. 2. New York: Thieme; 2013.
Arya A, D’Cruz A. Infratemporal fossa, masticator space and parapharyngeal space: can the radiologist and surgeon speak the same language? AIJOC. 2012;4(3):125–35. doi: 10.5005/jp-journals-10003-1098.
Wierzbicka M, Kopeć T, Szyfter W, Kereiakes T, Bem G. The presence of facial nerve weakness on diagnosis of a parotid gland malignant process. Eur Arch Otorhinolaryngol. 2012;269(4):1177–82. doi:10.1007/s00405-011-1882-6, PMCID: PMC3311986. Published online Dec 18, 2011.
Preis M, Soudry E, Bachar G, Shufel H, Feinmesser R, Shpitzer T. Predicting facial nerve invasion by parotid gland carcinoma and outcome of facial reanimation. Arch Otorhinolaryngol. 2010;267(1):107–11. doi:10.1007/s00405-009-0968-x.
Miyamoto H, Matsuura H, Wilson DF, Goss AN. Malignancy of the parotid gland with primary symptoms of a temporomandibular disorder. J Orofac Pain. 2000;14(2):140–6.
Vourexakis Z. Tonsillar asymmetry from a parotid tumor. N Engl J Med. 2014;370:e20. doi:10.1056/NEJMicm1310638.
Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Cassisi NJ. Radiation therapy for squamous cell carcinoma of the tonsillar region: a preferred alternative to surgery? J Clin Oncol. 2000;18(11):2219–25.
Marks MW, Ryan RF, Litwin MS, Sonntag BV. Squamous cell carcinoma of the parotid gland. Plast Reconstr Surg. 1987;79(4):550–4.
Teo PM, Chan AT, Lee WY, Leung SF, Chan ES, Mok CO. Failure patterns and factors affecting prognosis of salivary gland carcinoma: retrospective study. Hong Kong Med J. 2000;6:29–36.
Terhaard CHJ, Lubsen H, Van der Tweel I, Hilgers FJM, Eijkenboom WMH, Marres HAM, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch Head and Neck Oncology Cooperative Group. Head Neck. 2004;26(8):681–92; discussion 692–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Popescu, E.I., Costan, VV. (2016). Extended Parotid Tumors with Origin in the Parotid Tissue. In: Costan, VV. (eds) Management of Extended Parotid Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-26545-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-26545-2_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26543-8
Online ISBN: 978-3-319-26545-2
eBook Packages: MedicineMedicine (R0)